The role of fecal microbiota transplantation in diabetes
Acta Diabetologica · 19.04.2025 · 62 (7) · 977-981
DOI: 10.1007/s00592-025-02508-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Diabetologica, online erschienen am 19.04.2025. Verfasst von Gabriele Angelo Vassallo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Barone Lombardo Hospital, Canicattì, Italy. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Cattolica del Sacro Cuore.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic strategy for modulating gut dysbiosis in diabetes mellitus. This review critically evaluates preclinical and clinical evidence on FMT in type 1 (T1D) and type 2 diabetes (T2D). Studies suggest that FMT can restore microbial diversity, improve glycemic control, and modulate immune responses, with varying effects across diabetes subtypes. In T1D, preclinical models demonstrate that FMT influences regulatory T-cell expansion and β-cell preservation, though clinical translation remains limited. In T2D, FMT has shown transient improvements in insulin sensitivity, with sustained effects observed only in patients with specific microbiome signatures. However, heterogeneity in patient responses, donor variability, and methodological limitations complicate its clinical application. This review highlights the interplay between FMT, immune modulation, and microbial metabolism, advocating for phenotype-stratified trials and multi-omics integration to enhance therapeutic precision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Barone Lombardo Hospital, Canicattì, Italy.
- Internal Medicine and Alcohol Related Disease Unit, Columbus-Gemelli Hospital, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. tommaso.dionisi01@icatt.it.
- Department of Medical and Surgical Sciences, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy. tommaso.dionisi01@icatt.it.
- Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Medical and Surgical Sciences, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.
- CEMAD Digestive Disease Center, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Förderung
- Università Cattolica del Sacro Cuore
Zitieren
APA
Vassallo, G. A., Dionisi, T., De Vita, V., Augello, G., Gasbarrini, A., Pitocco, D., & Addolorato, G. (2025). The role of fecal microbiota transplantation in diabetes. Acta Diabetologica, 62(7), 977-981. https://doi.org/10.1007/s00592-025-02508-0
Vancouver
Vassallo GA, Dionisi T, De Vita V, Augello G, Gasbarrini A, Pitocco D, et al. The role of fecal microbiota transplantation in diabetes. Acta Diabetologica. 2025;62(7):977-981. doi:10.1007/s00592-025-02508-0
BibTeX
@article{Vassallo2025,
author = {Vassallo, Gabriele Angelo and Dionisi, Tommaso and De Vita, Vittorio and Augello, Giuseppe and Gasbarrini, Antonio and Pitocco, Dario and Addolorato, Giovanni},
title = {The role of fecal microbiota transplantation in diabetes},
journal = {Acta Diabetologica},
year = {2025},
volume = {62},
number = {7},
pages = {977--981},
doi = {10.1007/s00592-025-02508-0}
}
EUVIMED